Unlicensed and off-label drugs: What do we know?
Drug Discovery World
JULY 13, 2023
Following the death of a cancer patient after they were given an unlicensed drug, Diana Spencer unpacks the practice of prescribing unlicensed and off-label medicines. This month, a cancer patient died and three others were hospitalised in the UK after they were administered an unlicensed version of the chemotherapy drug cabazitaxel. In a statement, the company at fault claimed the problem was caused by an issue at its medicines manufacturing unit.
Let's personalize your content